Fitness

Activist investor Starboard Value said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose the drug-maker’s acquisition of Celgene. “Bristol-Myers is deeply undervalued and the recent announcement of the Company’s proposed acquisition of Celgene Corporation is poorly conceived and ill-advised,” Starboard CEO Jeffrey Smith wrote in a letter to Bristol-Myers shareholders.
0 Comments
U.S. Rep. Nita Lowey criticized Food and Drug Administration Commissioner Scott Gottlieb for delaying a regulation that would have temporarily removed electronic cigarettes from the market in 2016, saying it helped fueled an epidemic in teen use and calling it a “big, big whopping mistake.” “The FDA’s decision to take its foot off the gas
0 Comments
A senate panel on Tuesday grilled AbbVie Chairman and CEO Richard Gonzalez about the U.S. drugmaker’s arthritis treatment Humira, saying that tying executive bonuses to sales of the blockbuster drug was “problematic.” Humira’s $18.3 billion in 2017 sales — which rose 14.6 percent from the previous year and accounted for about 65 percent of the
0 Comments
Whether you want to dominate the rowing machine or just crush that #FlexFriday pic, it’s time to turn your attention to the biceps curl. This move is incredibly basic—but building front-of-arm strength has a ripple effect: “Strong biceps are important for more than just vanity,” says Cara Bonney, a Club Pilates master trainer in Dallas. “They’re involved
0 Comments
Top executives from seven of the largest pharmaceutical companies are set to testify Tuesday before the Senate Finance Committee. The congressional hearing, called “Drug Pricing in America: A Prescription for Change, Part II,” sets up a potentially hostile showdown between Washington and drugmakers, who face the threat of legislative action after years of setting drug
0 Comments